-
EP2363479
European procedure
Extract from the Register of European Patents
EP About this file: EP2363479
| EP2363479 - Oligoribonucucleotide for inhibiting the expression of a predefined gene [Right-click to bookmark this link] | Status | Opposition rejected Status updated on 12.10.2018 Database last updated on 09.09.2024 | |
| Former | The patent has been granted Status updated on 24.06.2018 | Most recent event Tooltip | 12.10.2018 | Opposition rejected | published on 14.11.2018 [2018/46] | Applicant(s) | For all designated states Alnylam Europe AG Fritz-Hornschuch-Strasse 9 95326 Kulmbach / DE | [2011/36] | Inventor(s) | 01 /
Kreutzer, Roland c/o Alnylam Pharmaceutical, Inc. 300 Third Street Cambridge, Massachusetts 02142 / US | 02 /
Limmer, Stephan c/o Alnylam Pharmaceutical, Inc. 300 Third Street Cambridge, Massachusetts 02142 / US | [2011/36] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2016/28] |
| Former [2011/36] | Vossius & Partner Siebertstrasse 4 81675 München / DE | Application number, filing date | 10011217.6 | 29.01.2000 | [2011/36] | Priority number, date | DE19991003713 | 30.01.1999 Original published format: DE 19903713 | DE19991056568 | 24.11.1999 Original published format: DE 19956568 | [2011/36] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | EP2363479 | Date: | 07.09.2011 | Language: | DE | [2011/36] | Type: | B1 Patent specification | No.: | EP2363479 | Date: | 13.07.2016 | Language: | DE | [2016/28] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 08.08.2011 | Classification | IPC: | C12N15/11, A61K31/713, A61K9/127 | [2011/36] | CPC: |
A61K31/713 (EP,US);
C12N15/113 (US);
A61P25/28 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/10 (EP);
A61P31/12 (EP);
A61P31/20 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
C12N15/111 (EP,US);
A61K38/00 (EP,US);
C12N2310/111 (EP,US);
C12N2310/14 (EP,US);
C12N2310/53 (EP,US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2011/36] | Title | German: | Oligoribonukleotid zur Hemmung der Expression eines vorgegebenen Gens | [2011/36] | English: | Oligoribonucucleotide for inhibiting the expression of a predefined gene | [2011/36] | French: | Oligoribonucléotide destiné à inhiber l'expression d'un gène donné | [2011/36] | Examination procedure | 27.10.2010 | Examination requested [2011/36] | 09.10.2013 | Despatch of a communication from the examining division (Time limit: M04) | 19.02.2014 | Reply to a communication from the examining division | 02.09.2015 | Despatch of a communication from the examining division (Time limit: M04) | 05.11.2015 | Reply to a communication from the examining division | 18.01.2016 | Communication of intention to grant the patent | 25.05.2016 | Fee for grant paid | 25.05.2016 | Fee for publishing/printing paid | 25.05.2016 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP00910510.7 / EP1144623 | EP02003683.6 / EP1214945 | EP05002454.6 / EP1550719 | EP06025389.5 / EP1798285 | Divisional application(s) | EP15194718.1 / EP3018207 | Opposition(s) | Opponent(s) | 01
13.04.2017
ADMISSIBLE Silence Therapeutics GmbH Robert-Rössle-Strasse 10 13125 Berlin / DE Opponent's representative Stephen, Robert John CMS Cameron McKenna Nabarro Olswang LLP Cannon Place 78 Cannon Street London EC4N 6AF / GB | [N/P] |
| Former [2017/20] | |||
| Opponent(s) | 01
13.04.2017
ADMISSIBLE Silence Therapeutics GmbH Robert-Rössle-Strasse 10 13125 Berlin / DE Opponent's representative Stephen, Robert John Olswang LLP 90 High Holborn London WC1V 6XX / GB | 18.05.2017 | Invitation to proprietor to file observations on the notice of opposition | 26.09.2017 | Reply of patent proprietor to notice(s) of opposition | 18.06.2018 | Cancellation of oral proceeding that was planned for 02.07.2018 | 25.06.2018 | Date of despatch of rejection of opposition | 02.07.2018 | Date of oral proceedings | 05.07.2018 | Legal effect of rejection of opposition [2018/46] | Fees paid | Renewal fee | 13.01.2011 | Renewal fee patent year 03 | 13.01.2011 | Renewal fee patent year 04 | 13.01.2011 | Renewal fee patent year 05 | 13.01.2011 | Renewal fee patent year 06 | 13.01.2011 | Renewal fee patent year 07 | 13.01.2011 | Renewal fee patent year 08 | 13.01.2011 | Renewal fee patent year 09 | 13.01.2011 | Renewal fee patent year 10 | 13.01.2011 | Renewal fee patent year 11 | 25.01.2011 | Renewal fee patent year 12 | 25.01.2012 | Renewal fee patent year 13 | 25.01.2013 | Renewal fee patent year 14 | 27.01.2014 | Renewal fee patent year 15 | 27.01.2015 | Renewal fee patent year 16 | 27.01.2016 | Renewal fee patent year 17 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]WO9219732 (GENSET SA [FR]) [X] 1-4,6-11 * Zusammenfassung, Seite 11 Z.18-28, Seiten 12-13, Seite 15 Z.22 bis Seite 20 Z.1, Seiten 33 und 46, Abbildungen 1-6 * [Y] 5,12-15; | [Y]WO9705266 (INTROGENE BV [NL], et al) [Y] 13,14 * the whole document *; | [Y]WO9805770 (DEUTCHES KREBSFORSCHUNGSZENTRU [DE], et al) [Y] 1-15 * Zusammenfassung, Seiten 2-3 *; | [AP]WO9953050 (COMMW SCIENT IND RES ORG [AU], et al) [AP] 1-32* the whole document *; | [E]WO0063364 (AMERICAN HOME PROD [US], et al) [E] 1-15 * page 3, lines 11-16 * * page 8, lines 6-8 * * page 9, lines 5-7,16,17 * * page 17, lines 16,17 * * page 18, lines 17-19 * * page 19, lines 4-6 * * page 20, lines 8-12, 17-22 * * page 23, lines 8-14 * * page 27, lines 1-10 * * page 29, lines 4-6,18-20 * * page 28, lines 25,26 * * page 30, lines 17-20 *; | [Y] - UHLMANN E ET AL, "ANTISENSE OLIGONUCLEOTIDES: A NEW THERAPEUTIC PRINCIPLE", CHEMICAL REVIEWS,US,AMERICAN CHEMICAL SOCIETY. EASTON, (19900601), vol. 90, no. 4, ISSN 0009-2665, pages 543 - 584, XP000141412 [Y] 1-15 * Seiten 558,565-566,574-575 * DOI: http://dx.doi.org/10.1021/cr00102a001 | [Y] - GRYAZNOV S M ET AL, "Template controlled coupling and recombination of oligonucleotide blocks containing thiophosphoryl groups.", NUCLEIC ACIDS RESEARCH. 25 MAR 1993, (19930325), vol. 21, no. 6, ISSN 0305-1048, pages 1403 - 1408, XP002326215 [Y] 8-11 * the whole document * | [Y] - SKRIPKIN E ET AL, "Psoralen crosslinking between human immunodeficiency virus type 1 RNA and primer tRNA3(Lys).", NUCLEIC ACIDS RESEARCH. 1 FEB 1996, (19960201), vol. 24, no. 3, ISSN 0305-1048, pages 509 - 514, XP002326216 [Y] 8-11 * the whole document * DOI: http://dx.doi.org/10.1093/nar/24.3.509 | [A] - MONTGOMERY M K ET AL, "DOUBLE-STRANDED RNA AS A MEDIATOR IN SEQUENCE-SPECIFIC GENETIC SILENCING AND CO-SUPPRESSION", TRENDS IN GENETICS, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, (199807), vol. 14, no. 7, ISSN 0168-9525, pages 255 - 258, XP002939521 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/S0168-9525(98)01510-8 | [A] - FIRE ANDREW ET AL, "Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, (19980219), vol. 391, no. 6669, ISSN 0028-0836, pages 806 - 811, XP002199982 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1038/35888 | Examination | WO0136646 | Opposition | WO9932619 | WO0044914 | WO2004015107 | - WU et al., "Identification and partial purification of human double strand RNase activity. A novel terminating mechanism for oligoribonucleotide antisense drugs", J. Biol. Chem., (19980000), vol. 273, no. 5, pages 2532 - 2542, XP002234692 DOI: http://dx.doi.org/10.1074/jbc.273.5.2532 | - ELBASHIR SM et al., "Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate", The EMBO Journal, (20010000), vol. 20, no. 23, pages 6877 - 6888, XP002225998 DOI: http://dx.doi.org/10.1093/emboj/20.23.6877 | - CZAUDEMA F et al., "Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells", Nucleic Acids Research, (20030000), vol. 31, no. 11, pages 1 - 12, XP002270732 DOI: http://dx.doi.org/10.1093/nar/gkg393 | - SCHWARZ DS et al., "Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways", Molecular Cell, (20020900), vol. 10, pages 537 - 548, XP002257820 DOI: http://dx.doi.org/10.1016/S1097-2765(02)00651-2 | - DOENCH JG et al., "siRNAs can function as miRNAs", Genes & Dev, (20030215), vol. 17, no. 4, pages 438 - 442, XP002982608 DOI: http://dx.doi.org/10.1101/gad.1064703 | - MANCHE, L. et al., "INTERACTIONS BETWEEN DOUBLE-STRANDED RNA REGULATORS AND THE PROTEINKINASE DAI", Molecular and Cellular Biology, (19921100), pages 5238 - 5248, XP001009924 | - ZHENG X. et al., "Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tails", RNA, (20041200), vol. 10, pages 1934 - 1945, XP055377706 DOI: http://dx.doi.org/10.1261/rna.7150804 | - MONTGOMERY et al., "DOUBLE-STRANDED RNA AS A MEDIATOR IN SEQUENCE-SPECIFIC GENETIC SILENCING AND CO-SUPPRESSION", TRENDS IN GENETICS, (19980700), vol. 14, no. 7, pages 255 - 258, XP002939521 DOI: http://dx.doi.org/10.1016/S0168-9525(98)01510-8 | - HOMUNG et al., "Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7", Nature Medicine, (20050300), vol. 11, no. 3, pages 263 - 270, XP002371477 DOI: http://dx.doi.org/10.1038/nm1191 | - JUDGE et al., "Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA", Nature Biotechnology, (20050400), vol. 23, no. 4, pages 457 - 462, XP002371480 DOI: http://dx.doi.org/10.1038/nbt1081 | - SLEDZ, C.A. et al., "ACTIVATION OF THE INTERFERON SYSTEM BY SHORT-INTERFERING RNAS", Nature Cell Biology, (20030900), vol. 5, no. 9, pages 834 - 839, XP009043516 DOI: http://dx.doi.org/10.1038/ncb1038 | - Beigelman et al., "CHEMICAL MODIFICATION OF HAMMERHEAD RIBOZYMES. ÖCATALYTIC ACTIVITY AND NUCLEASE RESISTANCE", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (19951027), vol. 270, no. 43, pages 25702 - 25708, XP000601905 DOI: http://dx.doi.org/10.1074/jbc.270.43.25702 | - FIRE et al., "Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans", Nature, (19980219), vol. 39, pages 806 - 811, XP002095876 DOI: http://dx.doi.org/10.1038/35888 |